Min Qi

ORCID: 0000-0001-8116-9227
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hepatitis B Virus Studies
  • Medicinal Plant Pharmacodynamics Research
  • Liver Disease Diagnosis and Treatment
  • Neurological Disorders and Treatments
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Pulmonary Hypertension Research and Treatments
  • Clinical Nutrition and Gastroenterology
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Chemical Reactions and Isotopes
  • Liver Disease and Transplantation
  • Pharmacological Effects of Natural Compounds
  • Hepatitis C virus research
  • Electrochemical sensors and biosensors
  • Spectroscopy Techniques in Biomedical and Chemical Research
  • Drug-Induced Hepatotoxicity and Protection
  • Cerebrovascular and Carotid Artery Diseases
  • Biosensors and Analytical Detection

Luoyang Central Hospital Affiliated to Zhengzhou University
2012-2019

State Key Laboratory of Medicinal Chemical Biology
2018

Nankai University
2018

Second Affiliated Hospital of Jilin University
2013

This study aimed to investigate the role of 5-lipoxygenase (5-LO) in acute liver failure (ALF) and changes macrophage activation by blocking it. ALF was induced rats administration D-galactosamine (D-GalN)/lipopolysaccharide (LPS). Rats were injected intraperitoneally with AA-861 (a specific 5-LO inhibitor), 24 hr before D-GalN/LPS administration. After injection, tissue collected for assessment histology, microstructure, counts, mRNA formation, protein expression, concentration...

10.1155/2014/697560 article EN cc-by Journal of Immunology Research 2014-01-01

To analyze clinical significance of preoperative liver stiffness measurement (LSM) by FibroScan in postcurative resection hepatitis B virus (HBV) related hepatocellular carcinoma (HCC).A total 263 patients underwent LSM and curative operation for primary HBV-positive HCC were enrolled. The correlation between survival was analyzed.All stratified into two groups using the optimal cut-off value (13.2 kPa) receiver-operating characteristic. Patients with an ≥13.2 kPa had poorer overall (median,...

10.2217/fon-2017-0281 article EN cc-by-nc-nd Future Oncology 2017-11-30

Abstract Currently, the global healthcare market is increasing at high speed with impendent aging issue. Healthcare Industry 4.0 has emerged as an efficient solution towards issue since it was integrated ubiquitous medical sensors, big health processing platform, bandwidth, technologies, and services, etc. It believed to fulfil requirement of tremendously growing market. The acquisition data acts dominant precondition implement 4.0. In same way, widely available smartphone could serve best...

10.1002/elps.201900136 article EN Electrophoresis 2019-05-14

Objective We detected the proliferation inhibition effect of staphylococcal enterotoxin A (SEA) on human liver cancer SSMC7721 cell lines in vitro to provide a theoretical basis for therapy cancer.Methods applied MTT colorimetric method assay cell's rate treated by different concentrations (0 μg/L,20 μg/L,40 μg/L and 80 μL) SEA.We decided changes cycle progression flow cytometry apoptosis fluorescence microscopy.Results When cells were with concentrations(20 μg/L) SEA,cell rates (18.4 ± 1.3)...

10.3760/cma.j.issn.1008-6315.2013.01.005 article EN 中国综合临床 2013-01-01

Objective To observe the clinical efficacy of chronic hepatitis B (CHB) treated with baicalin capsules combined entecavir tablets.Methods One hundred and eighty-two patients CHB were randomly divided into treatment group control group.Ninety-one in administered orally (0.5 g,tid) tablets mg,qd,for 18 months).Ninety-one had only accepted therapy same course to group.Results At end therapy,the data ALT normalized ratio,HBeAg negative converted ratio,HBeAg/HBeAb sero conversion ratio HBVDNA...

10.3760/cma.j.issn.1674-4756.2012.20.018 article EN Central Plains Medical Journal 2012-10-25
Coming Soon ...